Literature DB >> 2510332

Role of endothelium in chronic inflammation.

M Ziff1.   

Abstract

The character of the immunologically stimulated chronic inflammatory infiltrate is to a considerable extent determined by nonspecific factors governing mononuclear cell traffic. The volume, composition and distribution of this traffic is strongly dependent on an initial adhesive interaction between circulating mononuclear cells and the EC of the PCV of the involved tissues. The emigration of lymphocytes from the PCV is preceded by binding of the lymphocytes to the endothelial lining cell. This binding is enhanced by lymphokines (IFN-gamma, TNF-beta) and monokines (IL-1, TNF-alpha), secreted by perivascular inflammatory cells and acting on the EC. This enhancement may permit an initial, immunologically generated small focus of mononuclear cells to amplify itself to a larger infiltrate. Movement of the EC-bound lymphocyte through the endothelium may be facilitated by IFN-gamma, as suggested by evidence that T cells, bound to the surface of EC monolayers overlying nitrocellulose filters, migrate through these monolayers in increased numbers in the presence of IFN-gamma. Movement of the lymphocyte through the wall of the PCV and subsequently through the perivascular space toward the inflammatory focus may be enhanced by the chemotactic action of IL-1, generated by the macrophages of the perivascular infiltrate. The lining layer of the synovial membrane may play an important role in the development of synovitis. Hyperplasia of the synovial lining layer is associated with the secretion of chemotactic agents which can attract monocytes from the PCV toward the lining. The continuous movement of monocytes from PCV to lining may establish a steady-state population of macrophage-like cells in the interstitium of the synovium. These may provide the accessory cell population required for the immune responses which give rise to the various chronic inflammatory synovitides. The sublining layer of the rheumatoid synovium does, in fact, contain large numbers of DR+macrophage+ cells which may represent this accessory cell population. Since the cytokines mediate the inflammatory effects of the cellular immune response, it follows that when injected intraarticularly they should produce synovial inflammation. Such inflammation has, in fact, been produced in experimental animals by the intraarticular injection of supernatants of antigen-stimulated PBMC or of rIL-1. A cytokine-mediated chronic inflammatory reaction may be expected to assemble a polyclonal population of lymphocytes around the PCV. However, the fraction of the accumulated T cells which is antigen reactive is not entirely a random one as indicated by the following.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510332     DOI: 10.1007/bf00197189

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  80 in total

1.  Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation.

Authors:  T Iguchi; M Ziff
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

2.  Changes in vascular endothelium related to lymphocyte collections in diseased synovia.

Authors:  A J Freemont; C J Jones; M Bromley; P Andrews
Journal:  Arthritis Rheum       Date:  1983-12

3.  The origin of phagocytic cells in the joint and bone.

Authors:  R van Furth
Journal:  Scand J Rheumatol Suppl       Date:  1981

4.  Human dermal microvascular endothelial cells behave like umbilical vein endothelial cells in T-cell adhesion studies.

Authors:  D O Haskard; D Cavender; R M Fleck; R Sontheimer; M Ziff
Journal:  J Invest Dermatol       Date:  1987-03       Impact factor: 8.551

5.  The rheumatoid synovial membrane participates in systemic anti-viral immune responses.

Authors:  B K Pelton; A R Harvey; A M Denman
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

6.  Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor.

Authors:  D Cavender; Y Saegusa; M Ziff
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

7.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.

Authors:  E R Pettipher; G A Higgs; B Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint.

Authors:  C Pitzalis; G Kingsley; J Murphy; G Panayi
Journal:  Clin Immunol Immunopathol       Date:  1987-11

9.  Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction.

Authors:  O Førre; J H Dobloug; J B Natvig
Journal:  Scand J Immunol       Date:  1982-02       Impact factor: 3.487

10.  Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.

Authors:  S M Wahl; D A Hunt; H L Wong; S Dougherty; N McCartney-Francis; L M Wahl; L Ellingsworth; J A Schmidt; G Hall; A B Roberts
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

View more
  9 in total

1.  Physiologic-chemoattractant-induced migration of polymorphonuclear leukocytes in milk.

Authors:  N Manlongat; T J Yang; L S Hinckley; R B Bendel; H M Krider
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

Review 2.  T cell regulation and T cell clones in relation to synovial inflammation.

Authors:  G R Burmester; B Jahn; N Hain; G Strobel; J R Kalden
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Phospholipase A2 (PLA2) activity in bovine pulmonary artery endothelial cells.

Authors:  R Goodman; T M Stevens; L R Mantegna; P R Kidd; R R Harris; J S Kerr
Journal:  Agents Actions       Date:  1991-09

4.  Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.

Authors:  Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

5.  Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

Authors:  A A Postigo; R Garcia-Vicuña; F Diaz-Gonzalez; A G Arroyo; M O De Landázuri; G Chi-Rosso; R R Lobb; A Laffon; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

6.  Augmented lymphocyte binding to cultured endothelium in psoriasis.

Authors:  M L Lee; S S To; A Cooper; M Jones; L Schrieber
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

7.  Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

Authors:  A Laffón; R García-Vicuña; A Humbría; A A Postigo; A L Corbí; M O de Landázuri; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

8.  Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production.

Authors:  C M Hawrylowicz; G L Howells; M Feldmann
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

Review 9.  Current perspectives on synovitis.

Authors:  P P Tak; F C Breedveld
Journal:  Arthritis Res       Date:  1999-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.